Erector Spinae Plane Blocks for the Early Analgesia of Rib Fractures in Trauma: a Feasibility Randomised Controlled Trial With Embedded Qualitative Assessment
ESPEAR
1 other identifier
interventional
27
1 country
3
Brief Summary
To assess the feasibility and inform the design and conduct of a pragmatically conducted, interventional, multi-centre RCT in adult patients admitted to UK major trauma centres with rib fractures examining ESP block as an analgesic adjunct to existing multimodal analgesia in the early management of rib fracture pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2022
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2024
CompletedFirst Submitted
Initial submission to the registry
December 15, 2025
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedMarch 27, 2026
March 1, 2026
1.6 years
December 15, 2025
March 20, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Recruitment rate vs target
Defined as the number of eligible participants who consent to participate in the trial as a percentage of all eligible participants. This will be presented per centre per month and measured over the recruitment period (from randomisation of the first participant to randomisation of the 50th participant). The target recruitment rate is defined as recruitment of 50 participants from three recruiting centres, with each centre being open to recruitment for 12 months. This produces a mean trial target recruitment rate of 1.4 participants per centre per month.
18 months
Retention rate
Defined as the proportion of randomised participants who complete 6-week follow-up with valid candidate clinical outcomes data. Barriers and facilitators to recruitment and retention among participants and recruitment site staff (anaesthetists, allied health professionals, surgeons and research staff). This will be assessed in the embedded qualitative study.
18 months
Qualitative feedback
Qualitative research will be embedded within the ESPEAR RCT feasibility trial to provide insights into the feasibility and design of a main RCT trial. It will focus on two key aspects: Understanding the acceptability and feasibility of delivering the intervention/control in practice Exploring patients' experience of trial participation and acceptability of interventions The aim of this qualitative work is to enrich the quantitative data collected. The qualitative study intends to provide insight into processes used for research delivery and highlight where these processes vary between centres. Identification of barriers to recruitment will facilitate improvements in trial design should this feasibility trial proceed to a full trial. The trial will use multiple approaches to qualitative data-collection to optimize data collection.
18 months
Secondary Outcomes (6)
Screening rate
18 months
Eligibility rate
18 months
Consent rate
18 months
Protocol violations
2 years
Trial withdrawals
2 years
- +1 more secondary outcomes
Study Arms (2)
ESP Block
ACTIVE COMPARATORESP Block
Placebo
PLACEBO COMPARATORPlacebo
Interventions
Eligibility Criteria
You may qualify if:
- Age ≥ 18 Mechanism of injury blunt thoracic trauma Radiographic evidence of 1 or more new traumatic rib fractures Moderate or severe unilateral acute pain (defined as 11-point numerical rating scale (NRS) pain \>4 when patient performing vital capacity breath or effective cough) at time of enrolment. Patients may have bilateral fractures, but pain must be unilateral.
You may not qualify if:
- Patient refusal or inability to give informed written consent for any reason Thoracic injury requiring emergent operative or interventional radiology management Allergy to local anaesthetic Infection at site of ESP block Actual or estimated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Barts Health NHS Trust
London, United Kingdom
Manchester University NHS Foundation Trust
Manchester, United Kingdom
Queens Medical Centre
Nottingham, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Only anesthetist will be un blinded. Research nurse and participant will be blinded to treatment arm.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 15, 2025
First Posted
March 27, 2026
Study Start
July 1, 2022
Primary Completion
February 12, 2024
Study Completion
February 12, 2024
Last Updated
March 27, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share